Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Polycystic Ovary Syndrome × Phenotype × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Hyperandrogenism 1

Interventions

Metformin 134 Clomiphene 46 Letrozole 37 Inositol 31 Progesterone 16 Folic Acid 16 Exercise 14 Chorionic Gonadotropin 13 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Estradiol 12 Caloric Restriction 12 cetrorelix 11 Contraceptives, Oral 11 Cholecalciferol 10 Triptorelin Pamoate 9 Spironolactone 9 Pioglitazone 9 Tablets 8 Menotropins 8 High-Intensity Interval Training 8 Diet 8 Gonadotropins 7 Acupuncture Therapy 7 follitropin alfa 6 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Flutamide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02611128 2023-11-02

DENND1A

University of Virginia

Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon ⚡